Related Experiment Video
Updated: Jun 2, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Estrogen receptor β: switching to a new partner and escaping from estrogen
1Division of Environmental Genetics and Molecular Toxicology, Department of Environmental Health, University of Cincinnati Medical Center, Kettering Complex, Room 128, 3223 Eden Avenue, P.O. Box 670056, Cincinnati, OH 45267, USA.
Abstract:
Estrogen receptor (ER) β, the "second" ER, plays a gatekeeper role by inhibiting cell proliferation, promoting apoptosis, and impeding the progression of prostate cancer. Ironically, its presumed ligand, 17β-estradiol, promotes cancer development in experimental models. The mechanisms underlying the interplay between estrogens and ERβ in prostate cancer remain largely unclear. Research on a previously unknown tethering partner of ERβ, Krüppel-like zinc finger transcription factor 5 (KLF5), and its downstream gene target (FOXO1) helps to unlock this puzzle. 17β-Estradiol is not required to maintain the tumor-suppressive function of ERβ in the prostate, a tissue with limited estrogen availability; moreover, the presence of 17β-estradiol abrogates ERβ- and KLF5-mediated signaling and promotes cellular proliferation. Future research into ERβ will likely involve this estrogen independency and the preference for binding nonclassical DNA elements through tethering. The development of ERβ-based therapies may lead to improved drug efficacy.
Insights
Estrogen receptor beta (ERβ) suppresses prostate cancer, independent of 17β-estradiol. This receptor
Area of Science:
- Molecular Endocrinology
- Cancer Biology
- Prostate Cancer Research
Background:
- Estrogen receptor beta (ERβ) acts as a tumor suppressor in prostate cancer by inhibiting cell proliferation and promoting apoptosis.
- The role of its presumed ligand, 17β-estradiol, in prostate cancer is paradoxical, as it can promote cancer development in experimental models.
- The precise mechanisms governing the interaction between estrogens and ERβ in prostate cancer are not fully understood.
Purpose of the Study:
- To investigate the mechanisms underlying the interplay between estrogens and ERβ in prostate cancer.
- To explore the role of ERβ's tethering partner, Krüppel-like zinc finger transcription factor 5 (KLF5), and its downstream target FOXO1.
- To determine the requirement of 17β-estradiol for ERβ's tumor-suppressive function in the prostate.
Main Methods:
- Investigated the interaction between ERβ, KLF5, and FOXO1 in prostate cancer models.
- Assessed the impact of 17β-estradiol on ERβ and KLF5-mediated signaling pathways.
- Analyzed the functional consequences of these interactions on cell proliferation and apoptosis.
Main Results:
- 17β-estradiol is not essential for ERβ's tumor-suppressive activity in the prostate, a tissue with limited estrogen.
- The presence of 17β-estradiol diminishes ERβ- and KLF5-mediated signaling, paradoxically promoting cellular proliferation.
- Identified KLF5 as a novel tethering partner of ERβ, influencing its function through downstream targets like FOXO1.
Conclusions:
- ERβ's tumor-suppressive function in prostate cancer is estrogen-independent.
- 17β-estradiol abrogates ERβ/KLF5 signaling, highlighting a complex role in cancer progression.
- Future therapeutic strategies may leverage ERβ's estrogen-independent functions and nonclassical DNA binding via tethering partners.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Ending Relationships
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Hormonal Regulation
Hormonal Regulation

